Showing 22,152 results

Filters Content type: Editors' picks
Health monitoring in resource-limited settings

Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas

Editor's pick
Eurekalert Inf Dis
17 September 2014
Ageing & HIV

Unique Health Care Challenges for Older Adults with HIV

Editor's pick
BETA blog
17 September 2014
Undetectable viral load & treatment as prevention

ART quells genital HIV shedding throughout menstrual cycle

Editor's pick
International AIDS Society
17 September 2014
Hepatitis C symptoms & diagnosis

Uncovering cases of early HCV infection in HIV-positive men

Editor's pick
CATIE
17 September 2014
Men who have sex with men (MSM)

Call for same-sex SRE be statutory in all English schools

Editor's pick
NAT press release
16 September 2014
HIV prevention policy

Why Are HIV Rates So High in Russia?

Editor's pick
International Business Times
16 September 2014
Hepatitis C treatment

Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism

Editor's pick
Pharmalot
16 September 2014
New & experimental HIV treatments

First Single-Tablet PI Regimen With Darunavir and TAF at 48 Weeks

Editor's pick
NATAP
16 September 2014
PEP

What to Do When a Patient Admits an H.I.V. Phobia

Editor's pick
New York Times
16 September 2014
Hepatitis C treatment

Clash between state, drugmaker heats up as Legislature takes up Hepatitis C cost

Editor's pick
The Oregonian
16 September 2014
Side effects

Switch From Efavirenz to Rilpivirine Quells CNS Toxicity, Improves Sleep

Editor's pick
NATAP
16 September 2014
Hepatitis C treatment

Gilead signs pact with 7 firms for cheap copies of hepatitis C drug

Editor's pick
Reuters
15 September 2014
HIV testing programmes & uptake

New “peer navigator” program encourages at-home HIV testing

Editor's pick
Oakland North
15 September 2014
PrEP

HIV-fighting intravaginal ring research nets $20M from NIH

Editor's pick
Fierce Drug Delivery
15 September 2014
The search for a cure

Sharon Lewin appointed to lead Doherty Institute for Infection and Immunity

Editor's pick
Peter Doherty Institute
15 September 2014
PrEP

The Enfant Terrible of AIDS Activism Reaches a New Low

Editor's pick
Slate
15 September 2014
HIV & criminal law

US: County health officials get court order to stop HIV-infected man

Editor's pick
Seattle Times
15 September 2014
New & experimental hepatitis C treatment

AbbVie 3D hepatitis C regimen is well-tolerated in Phase 3 trials

Editor's pick
HIVandHepatitis.com
15 September 2014
New & experimental HIV treatments

Long acting HIV drugs to be developed

Editor's pick
University of Liverpool press release
15 September 2014
Contraception

Advocates Call for Full Funding of Research on HIV and Contraception

Editor's pick
RH Reality Check
15 September 2014
Pharmaceutical industry

Gilead to raise price for new hepatitis C drug above $84000

Editor's pick
Reuters
15 September 2014
PEP

Change to recommended regimen for post-exposure prophylaxis (PEP)

Editor's pick
Expert Advisory Group on AIDS (EAGA)
11 September 2014
The search for a cure

A "Bad Year" for HIV Cure Research? Experts Mix Realism and Hope

Editor's pick
The Body Pro
11 September 2014
The search for an HIV prevention vaccine

Researcher has a radical idea for a drinkable, probiotic HIV vaccine

Editor's pick
Washington Post (blog)
11 September 2014